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Abstract
Background: Postoperative pain is a common phenomenon after surgery and is closely associated with the
development of postoperative cognitive dysfunction (POCD). Persistent pain and systemic inflammation caused by
surgery have been suggested as key factors for the development of POCD. Fractalkine (CX3CL1) and its receptor,
the CX3C chemokine receptor 1 (CX3CR1), are known to play a key role in pain and inflammation signaling
pathways. Recent studies have shown that the regulation of CX3CR1/L1 signaling influences the development of
various diseases including neuronal diseases. We determined whether CX3CR1/L1 signaling is a putative therapeutic
target for POCD in a mouse model.
Methods: Adult (9–11 weeks) male mice were treated with neutralizing antibody to block CX3CR1/L1 signaling
both before and after surgery. Inflammatory and behavioral responses including pain were assessed postoperatively.
Also, CX3CR1 mRNA level was assessed. Hippocampal astrocyte activation, Mao B expression, and GABA expression
were assessed at 2 days after surgery following neutralizing antibody administration.
Results: The behavioral response indicated cognitive dysfunction and development of pain in the surgery group
compared with the control group. Also, increased levels of pro-inflammatory cytokines and CX3CR1 mRNA were
observed in the surgery group. In addition, increased levels of GABA and increased Mao B expression were
observed in reactive astrocytes in the surgery group; these responses were attenuated by neutralizing antibody
administration.
Conclusions: Increased CX3CR1 after surgery is both necessary and sufficient to induce cognitive dysfunction.
CX3CR1 could be an important target for therapeutic strategies to prevent the development of POCD.
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GABA, Hippocampus
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: koobn@yuhs.ac
1Department of Anesthesiology and Pain Medicine, Yonsei University College
of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea
2Anesthesia and Pain Research Institute, Yonsei University College of
Medicine, Seoul, Korea
Full list of author information is available at the end of the article
Cho et al. Journal of Neuroinflammation           (2021) 18:93 
https://doi.org/10.1186/s12974-021-02150-x
Background
Postoperative cognitive dysfunction (POCD) is a com-
mon neurological complication after surgery that is
accompanied by impaired learning and memory [1, 2].
Transient cognitive impairment after surgery can lead to
persistent cognitive dysfunction and dementia [3]. Al-
though age, surgical duration, infection, and inflamma-
tion have been identified as the factors that lead to
POCD, the exact physiological mechanism of POCD
pathogenesis and optimal strategies for treatment or pre-
vention of POCD remain unclear [4, 5]. Recently, neuro-
inflammation caused by systemic inflammation following
surgery has been suggested as a key factor for the devel-
opment of POCD [6, 7]. Persistent pain accompanied by
surgery can induce systemic inflammatory mediators,
and these factors lead to microglia activation. Conse-
quently, microglia activation induces release of cytokines
and other inflammatory mediators that have been associ-
ated with cognitive dysfunctions [8–11].
Cytokines and chemokines are important mediators in
inflammation and the pathophysiology of inflammatory
disease [12, 13]. Chemokines and other pain mediators
regulate the interplay between glial cells and neurons in
neuroinflammation and pain condition [14]. The neur-
onal chemokine fractalkine (CX3CL1) is a chemokine of
the CX3C family and was first described as a potent at-
tractant of immune cells [15, 16]. In the brain, CX3CL1
is expressed mainly in neurons while its receptor
CX3CR1 is expressed mainly in microglia. CX3CL1/R1
interaction plays an important role in modulating glial
activation in the central nervous system (CNS).
CX3CL1/R1 interactions are also vital for many homeo-
static processes, including the survival of blood mono-
cytes [17], wound healing [18], and endothelial
migration for immune surveillance [19, 20]. In addition,
changes in CX3CL1/R1 immunoreactivity accompanied
by microglia activation were detected after an ischemic
event [21]. Although the association between CX3CL1/
R1 signaling and POCD is established, the pathogenesis
of postoperative cognitive impairment has not been elu-
cidated. According to recent studies, the regulation of
neurotrophic factors including cytokines and chemo-
kines in the hippocampus, in response to systemic in-
flammation and pain after surgery, has been suggested
as a key factor involved in cognitive impairment in
POCD [22–24]. Consequently, alteration of neurotrophic
factors in the brain enhances gamma-aminobutyric acid
(GABA) release, which regulates neural activity by
modulating inhibitory and excitatory responses [25, 26].
The hippocampus is a dynamic brain structure that con-
sists of diverse neuronal cell types including neurons, as-
trocytes, and microglia, and is crucial for regulating
cognitive function. Alterations of GABA levels in the
hippocampus are involved in cognitive dysfunction in
many CNS diseases [27, 28]; hence, GABA is also a
target for the treatment of cognitive impairment in
schizophrenia and epilepsy [29, 30].
Tibial fracture (TF) surgery is one of the most widely
used animal models for POCD [22, 24]. In this study, we
examined changes in CX3CR1 expression levels in the
TF-induced POCD model and the potential therapeutic
effect of CX3CL1 as a new treatment candidate for alle-
viating cognitive impairment by regulating inflammation.
Also, this is the first study to show that the regulation of
CX3CR1/L1 can improve postoperative cognitive impair-
ment via modulation of GABA expression, which is
mediated by the regulation of astrocyte activation.
Materials and methods
Animals
All procedures involving animals were approved by the In-
stitutional Committee for the Care and Use of Laboratory
Animals at Yonsei University Health System. Adult (9–11
weeks) male C57BL/6 (Orient, Seongnam, GyeongGi-Do,
South Korea) mice were used for these experiments. All
mice were housed in a controlled animal facility at Yonsei
University. The mice were housed in groups of five per
cage on a 12-hour light/dark cycle with food and water
available ad libitum.
Study groups and surgery model
In experiment 1, the mice were randomly divided into
three sets to investigate alteration of neurobehavioral
function after surgery: control vs. 1 day after TF surgery,
control vs. 2 days after TF surgery, and control vs. 5 days
after TF surgery (n = 8~10). In experiment 2, the mice
were randomly divided into four groups as follows:
Control, TF surgery, neutralizing antibody (Ab)-TF sur-
gery and, neutralizing Ab-control (without surgery)
(total n = 5~13 per group). A schematic diagram of the
experimental procedure is shown in Fig. 1. In the TF
surgery group, TF surgery was performed as previously
described with small modifications [8, 31]. Briefly, mice
received a fracture under isoflurane anesthesia (2.0–3.0
% inspired concentration). An incision was made in the
right tibia after disinfection, and an intramedullary
fixation pin (Ø = 0.38 mm) was inserted into the bone
marrow cavity at the level of the tibial tuberosity to
create an osteotomy. Mice in the neutralizing Ab-TF
surgery group received neutralizing Ab (CX3CL1, 4 μg/
mouse, dissolved in 96 μL saline, i.p.; R&D Systems,
Minneapolis, MN, USA) 30 min before TF surgery after
behavioral training tests, and same time point 24 and 48
h later [32]. Mice in the TF surgery group were injected
with the same volume (100 μL) of saline. Control group
was anaesthetized with isoflurane without any surgical
procedure for approximately 10–15 min.
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Neurobehavioral tests
As depicted in the schematic diagram (Fig. 1), the mice
performed the training phase of the behavioral test 3 h
before surgery and the post behavioral tests 1, 2, and 5
days after surgery. All behavioral tests were conducted
in the same behavioral testing room at the same time.
To eliminate the influence of environmental novelty of
testing room conditions, the mice were placed in their
home cage in the behavioral testing room for a mini-
mum of 30 min in the absence of the experimenter. The
mice underwent multiple behavioral tests in the follow-
ing order: open field test, elevated plus maze test, novel
object recognition test, von Frey test, and finally, passive
avoidance test. Mice were tested in a random order.
During an interval time of 5 min between each test, the
behavioral apparatus was cleaned with distilled water
and 70% ethanol to eliminate olfactory cues.
An open field test was performed to assess exploratory
activity and the level of anxiety. Mice were tested in a
square open-field arena (40 × 40 × 40 cm) and behavior
was recorded for 5 min. The total distance traveled and
the time spent in the center zone were assessed.
For assessing the memory function of mice, the ele-
vated plus maze test was performed. The maze was 50
cm in height and consisted of two open arms (31 × 6 ×
1 cm) and two enclosed arms (31 × 6 × 15 cm), with a
central open square area (5 × 5 × 1 cm). While the mice
were allowed 5 min to explore the setting, we recorded
the time to enter the closed arms. Based on the natural
aversion of mice to high and open spaces, the learning
index is calculated as the difference in entering time (in
which the mouse first moves from the open arms to the
closed arm) of training period − entering time (in which
the mouse first moves from the open arms to closed
arm) of test period = learning index [8, 33–36].
To evaluate the recognition memory ability of mice,
the novel object recognition test was performed in a
square arena (40 × 40 × 40 cm) for 5 min. In the
familiarization phase, the mice were allowed to explore
two equal objects (●+●) for 5 min. In the test phase, one
Fig. 1 Schematic diagram of the experimental procedure. In experiment 1, the mice underwent behavioral tests for the training phase 3 h before
surgery and post behavioral tests 1, 2, and 5 days after surgery. Brain tissues were immediately harvested at the end of the behavioral testing,
and ELISA analysis for TNF-α, IL-6, and IL-1β levels was performed. The level of CX3CR1 mRNA was measured by RT-PCR. In experiment 2,
neutralizing Ab was injected 30 min before TF surgery after behavioral training tests, and at the same time point 24 and 48 h after later. The mice
performed behavioral tests for the training phase 3 h before surgery and post behavioral tests 2 days after surgery. The brain tissues were
harvested and ELISA and immunohistochemistry was performed after the behavioral testing period. For OIS imaging, the mice received the
cranial window implantation 3 weeks before surgery, and OIS imaging was performed 2 days after surgery
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object was changed to a novel object (●+■) placed
within the same physical location, and the mice were
allowed to explore both objects for 5 min. During both
the familiarization and test phases, the time spent ex-
ploring each object was measured and recorded. Recog-
nition memory ability was expressed as a percentage of
novel object discrimination during total exploration
time.
The passive avoidance test was used to evaluate learn-
ing and memory. We used a rectangular chamber
divided into dark and lit compartments. During the ac-
quisition phase, mice were placed into the lit compart-
ment and allowed to explore freely for a maximum of 5
min. When mice entered the dark compartment, they re-
ceived an electric shock (0.5 mA) for 3 s. In the test
phase, mice were placed in the lit compartment and the
time taken to enter the dark compartment was recorded.
All neurobehavioral tests were recorded on video and
analyzed with an image analyzing system (SMART
v2.5.21 software and SMART video Tracking system,
Panlab Harvard Apparatus, Barcelona, Spain).
To evaluate mechanical allodynia, the von Frey fila-
ment test (Bioseb Inc., Vitrolles, France) was performed
in accordance with a previously described method [37].
Briefly, the mice were individually placed in an acrylic
box with a metal mesh grid. Different von Frey fila-
ments, ranging from 2 to 60 g, were gradually applied
for up to 3 s to the mid-plantar area of the right hind-
paw in an ascending manner. Rapid retraction, shaking,
or licking of the hind paw at least three times in five
tests was considered to indicate a positive reaction.
Enzyme-linked immunosorbent assay (ELISA)
Animals were fully anaesthetized and perfused with
saline. The hippocampus, the prefrontal cortex, and
amygdala regions were isolated. To measure IL-1β, IL-6,
and TNF-α levels, tissues were lysed using tissue protein
extraction reagent (T-PER® Tissue Protein Extraction
Reagent, ThermoFisher Scientific™, Waltham, MA, USA)
containing a protease and phosphatase inhibitor cocktail
(100X Halt protease and phosphatase inhibitor cocktail,
#1861281 Thermo Scientific™) at 6,000×g for 10 min at 4
°C. Samples were analyzed with a high-sensitivity mouse
ELISA kit (Quantikine® ELISA, R&D Systems) according
to the manufacturer’s instructions. After the reaction
was complete, the results were read at 450 nm using a
microplate reader.
RT-PCR
The brains from mice in each group were rapidly dis-
sected, collected, and stored at – 70 °C until real-time
PCR was performed. Total RNA was extracted using the
HiGene™ Total RNA Prep kit (BIOFACT, Daejeon,
Korea) following the manufacturer’s instructions. Tissues
(< 30 mg) were lysed with β-mercaptoethanol and pro-
teinase K. After the samples were centrifuged at 18,
000×g for 3 min at 4 °C, ethanol (100 %) was added and
the mixture was vortexed for 30 s. The RNA was eluted
with 50–100 μL RNase-free water. The purity of RNA
was measured at 260/280 nm using NanoDrop® ND-
1000 (Thermo Fisher Scientific). The primers were
purchased from Bioneer (Daejeon, Korea) (CX3CR1
Forward, 5′ - CAGCATCGACCGGTACCTT - 3′; Re-
verse, 5′ - GCTGCACTGTCCGGTTGTT - 3′). PCR
was performed in a total reaction mixture volume of 20
μL, which was composed of One-step SYBR RT-PCR
Buffer, PrimeScript 1 step Enzyme Mix 2, ROX Refer-
ence Dye, forward primer and reverse primer, and sam-
ple RNA diluted in RNase-free distilled water according
to manufacturer’s protocol. One-step real-time PCR was
performed using the One-step SYBR PrimeScript RT-
PCR Kit II (Perfect Real Time; Takara Bio Inc., JAPAN)
on an ABI StepOnePlus Real-Time PCR system (Applied
Biosystems, Thermo Fisher Scientific). The PCR cycling
system was set as follows: reverse transcription was per-
formed for 5 min at 42 °C and for 10 s at 95 °C. The
PCR reaction was performed for 40 cycles of 5 s at 95 °C
and for 34 s at 60 °C. The final step was performed at 95
°C for 15 s, at 60 °C for 1 min, and at 95 °C for 15 s.
Cycling threshold values were normalized to the cycling
threshold values of β-actin. The results were analyzed
with the StepOneSoftware v2.3 (Thermo Fisher
Scientific).
Optical imaging system
To evaluate cerebral blood volume (CBV), hemodynamic
responses to whisker stimulation were recorded with an
optical imaging system (Imager 3001-Celox, Optical
Imaging). The cortex was exposed for chronic imaging
via cranial window surgery [38]. The animal was allowed
to recover for 3 weeks to avoid inflammation due to the
cranial window implantation procedure. The cranial
window was illuminated with an LED lamp (CLS150,
Leica Microsystems). Images were taken with a 10-Hz
frame rate using a CCD camera (Photonfocus AG)
through 50 mm tandem lenses at 546 nm wavelength,
an isosbestic wavelength in the absorption spectra of
oxyhemoglobin and deoxyhemoglobin, to assess CBV
changes. The reflected light was filtered with a 546 ± 30
nm bandpass filter to measure the total amount of
hemoglobin (Hbt). For whisker forelimb stimulation, air-
puff stimulation was applied for 15 s. The activated area
within the whisker cortex was identified and a region of
interest (ROI) was placed to assess CBV changes over
the course of 60 s. Optical intensity changes in these
ROIs were computed for each trial with the baseline de-
fined as the 5-s period preceding the whisker stimulus
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onset. Pixel changes compared to the baseline were cal-
culated and plotted over the 60 s period.
Immunofluorescence staining
Animals were fully anaesthetized and perfused with sa-
line and 4% formaldehyde. The brain was post-fixed with
4% formaldehyde in PBS for one day at 4 °C. Afterward,
the brain was dehydrated with 30% sucrose in PBS for at
least 3 days and then it was rapidly frozen with OCT
(optimal cutting temperature) compound. Coronal sec-
tions (20 μm) were cut using a cryotome. The sectioned
tissues were incubated with 3 % bovine serum albumin
and 0.3% Tx-100 in PBS for 1 h at room temperature
and incubated with the primary antibody (GFAP,
monoamine oxidase B (Mao B) and Iba-1; Cell Signaling
Technology) overnight at 4 °C. The fluorescence-
conjugated secondary antibody (1:200; Jackson) was ap-
plied for 1 hour at room temperature. Tissues were
mounted with Vectashield with 4′,6-diamidino-2-pheny-
lindole (DAPI; Vector Laboratories, USA). The stained
sections were observed using laser scanning (LSM 700
confocal) microscopy. For semi-quantitative estimation
of the staining intensity of Mao B expression, the fluor-
escence intensity of Mao B-stained regions was analyzed
by calculating their mean fluorescence intensity using
Zen 2010 software (Carl Zeiss). Sholl analysis was per-
formed using Image J (FIJI-Image J).
Statistical analysis
All quantitative data were analyzed using Prism software
v7.0 (GraphPad Software, USA). Statistically significant
differences between two groups were determined using
Welch’s t-tests. Data from multiple groups were
analyzed using one-, two-way ANOVA (Supplementary
Figure S2-4) followed by Tukey post hoc tests for mul-
tiple comparison. Results are expressed as group mean ±
SME. Statistical significance was set at p < 0.05.
Results
Cognitive dysfunctions and inflammatory responses in TF-
induced POCD mice
To assess the learning and memory ability in TF-
induced POCD mice, we performed longitudinal neuro-
behavioral tests following surgery. In the open-field test,
the total distance traveled did not show a significant
difference at 1, 2, and 5 days after surgery compared to
the control group (Fig. 2a; t-test, p = 0.3446, p = 0.1095,
p = 0.3508, respectively); however, the percentage of
Fig. 2 Assessment of neurobehavioral abilities of POCD mice. a Total distance traveled and b percentage of time in center zone in the open-field
test. c Latency to enter the dark compartment in the passive avoidance test. d Learning index (entering time in which a mouse first moves from
the open arms to closed arm during the training period − entering time in which a mouse first moves from the open arms to closed arm during
the test period) in the elevated plus maze test. e Discrimination time rate for novel objects in the test phase of the novel objective recognition
test (unpaired t-test, n = 8~11 per group). f Mechanical allodynia was performed using the von Frey test (two-way ANOVA with Tukey’s post hoc
test, n = 15 per group). Con, normal control group; TF, tibial fracture surgery group; 1D, 1 day after surgery; 2D, 2 days after surgery; 5D, 5 days
after surgery; AP, acquisition phase; TP, test phase; *p < 0.05 compared to the control; **p < 0.01 compared to the control
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time in the center zone was significantly decreased post-
surgically (Fig. 2b; t-test, p = 0.0002, p = 0.0046, p =
0.0015, respectively, n = 9–10). In the passive avoidance
test, the latency time was significantly decreased at 1, 2,
and 5 days after surgery during the test phase (Fig. 2c; t-
test, p = 0.0312, p = 0.0326, p = 0.0011, respectively). In
addition, the learning index in the elevated plus maze
test was significantly decreased 1, 2, and 5 days after
surgery compared to the control group (Fig. 2d; t-test, p
= 0.0058, p = 0.0015, p = 0.0025, respectively). The
exploring rate for new objects in the novel objective rec-
ognition test was also significantly decreased at 1, 2, and
5 days after surgery compared to the control group (Fig.
2e; t-test, p = 0.0452, p = 0.0007, p = 0.0173, respect-
ively). These data suggest that TF-induced POCD mice
have cognitive impairments and increased anxiety. To
evaluate pain after TF surgery, we performed the von
Frey test. The mechanical paw withdrawal threshold
(PWT) was decreased in the ipsilateral hindpaw from
days 1 to 5 in TF-induced POCD mice, compared with
that in the control mice (Fig. 2f; two-way ANOVA, p =
0.0038, p = 0.0024, p = 0.0002, respectively; F(3,112) =
12.26, p < 0.0001 [days], F(1,112) = 41.33, p < 0 .0001
[surgery], F(3,112) = 1.832, p = 0.1455 [interaction be-
tween days and surgery], n = 15), which indicated that
pain lasted up to 5 days after surgery.
To evaluate the inflammatory response in the brain re-
gions longitudinally following TF surgery, we measured
the protein expression levels of TNF-α, IL-6, and IL-1β
(Fig. 3a). Overall, IL-1β, IL-6, and TNF-α levels were in-
creased in TF surgery groups. Especially during the early
phase after surgery, such as at 2 h after surgery, the level
of TNF-α was significantly higher in POCD mice com-
pared to control (in hippocampus; one-way ANOVA, p
= 0.0179, n = 10). Furthermore, the level of IL-1β was
also significantly higher at 2 days after surgery compared
to the control (in hippocampus; one-way-ANOVA, p =
0.0225, n = 10). Consequently, TF-induced POCD mice
showed cognitive impairment and an elevated inflamma-
tory response.
Fig. 3 The level of pro-inflammatory cytokines and mRNA expression in POCD mice. a IL-1β, IL-6, and TNF-α in the prefrontal cortex, the
hippocampus, and the amygdala at different time points after tibial fracture surgery (one-way ANOVA with Tukey’s post hoc, n = 8~11 per
group). b The mRNA level of CX3CR1 in the prefrontal cortex, the hippocampus, and the amygdala at different time points after tibial fracture
surgery (one-way ANOVA with Tukey’s post hoc, n = 4~5 per group). Control, normal control group; TF, tibial fracture surgery group; 2hr, 2 h after
surgery; 6hr, 6 h after surgery; 24hr, 1 day after surgery; 2D, 2 days after surgery; 5D, 5 days after surgery; *p < 0.05 compared to the control
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Pain-mediated increase in CX3CR1 in POCD mice
We selected CX3CR1 as a chemokine related to pain
and chemotaxis in the brain to analyze following TF
surgery. Two days after surgery, CX3CR1 transcription
was significantly increased in the hippocampus (one-way
ANOVA, p = 0.0247, n = 5) and amygdala (one-way
ANOVA, p = 0.0213, n = 5) (Fig. 3b) based on RT-PCR
analysis. Therefore, the subsequent experiments were
performed 2 days after surgery in POCD mice.
Attenuation of cognitive dysfunction and inflammatory
response by blocking CX3CR1 signaling
To evaluate the effect of inhibiting CX3CR1 signaling,
we intraperitoneally injected the mice with neutralizing
Ab (4 μg/mice) 30 min before surgery and 24 and 48 h
after surgery. In the passive avoidance test, the latency
was significantly increased in the Ab-injected group
compared to the TF-induced POCD group (Fig. 4a, one-
way ANOVA, p < 0.0001, n = 5). The learning index in
the elevated plus maze test was also significantly
increased in the Ab-injected group compared to the TF-
induced POCD group (Fig. 4b, one-way ANOVA, p =
0.0130, n = 5). In addition, the exploration rate for new
objects in the novel objective recognition test was sig-
nificantly increased in the Ab-injected group (Fig. 4c,
one-way ANOVA, p = 0.0135, n = 5). In the open-field
test to assess anxiety levels, the rate of time spent in the
center zone was significantly decreased in the TF-
induced POCD group compared to the control group.
However, it was non-significantly increased in the Ab-
injected group (Fig. 4d, one-way ANOVA, p = 0.9066, n
= 5). Mechanical PWT in the von Frey test was signifi-
cantly increased in the Ab-injected group compared to
the TF-induced POCD group (Fig. 4e, one-way ANOVA,
p = 0.0222, n = 5).
To confirm the effect of inhibition of CX3CR1 signal-
ing on the inflammatory response in the brain regions,
we measured the expression levels of TNF-α, IL-6, and
IL-1β (Fig. 5). IL-1β expression was significantly
decreased in the prefrontal cortex (p = 0.0447, n = 5),
the hippocampus (p = 0.0016, n = 5), and the amygdala
(p = 0.0026, n = 5) regions in the Ab-injected group
compared to the TF-induced POCD group (one-way
ANOVA, n = 10). Overall, decreased levels of inflamma-
tory cytokines including TNF-α and IL-6 were detected
in the brain regions of Ab-injected mice.
These data suggest that inhibition of CX3CR1 signal-
ing attenuated cognitive dysfunction and inflammatory
response in TF-induced POCD mice.
Amelioration of the hemodynamic response to whisker
stimulation following CX3CR1 signal blocking
The regulation of brain blood flow is critical for brain
function [39, 40]. Abnormal changes in CBV responses
can lead to neuronal dysfunction and accelerated
neuronal damage and loss. Indeed, in some diseases ac-
companied by cognitive dysfunction, such as aging, de-
mentia, and Alzheimer’s disease, changes in central
blood flow and hemodynamics are found [41]. To assess
hemodynamic responses to sensory stimulation in the
Fig. 4 Evaluation of neurobehavioral abilities of POCD mice after inhibition of CX3CR1 signaling (one-way ANOVA with Tukey’s post hoc, n =
5~13 per group). a Latency to enter the dark compartment in the passive avoidance test 2 days after tibial fracture surgery. b Leaning index
(transfer latency time to enter the closed arm of the training period − transfer latency time to enter the closed arm during the test period) in the
elevated plus maze test. c Discrimination time rate for novel objects in the test phase of the novel objective recognition test. d Time rate in the
center zone in the open-field test. e Mechanical allodynia was evaluated with the von Frey test. Control, normal control group; TF2D, 2 days after
tibial fracture surgery group; TF+Ab, 2 days after tibial fracture surgery group injected with neutralizing Ab; Control+Ab, normal control group
injected with neutralizing Ab; *p < 0.05 compared to the control; #p < 0.05 compared to the TF2D; ###p < 0.0001 compared to TF2D
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POCD model, we performed optical intrinsic signal
(OIS) imaging [42]. In the control group, robust and
large changes of CBV were detected following whisker
stimulation. The maximum CBV change (2.04 ± 0.41 %)
was found at about 15 s (Fig. 6, n = 4). In POCD mice,
the maximum CBV was found at a similar time point in
the control group, but the peak CBV amplitude was sig-
nificantly lower than in the control group (1.13 ± 0.38%,
one-way ANOVA, p = 0.0048, n = 6). In the Ab-injected
group, the peak CBV amplitude was significantly in-
creased (1.87 ± 0.34%, one-way ANOVA, p = 0.0095, n
= 6) compared to the TF surgery group.
Normalization of astrocyte activation and GABA
expression by blocking CX3CR1 signaling
In the CNS, astrocytes play crucial roles including regu-
lating synaptic homeostasis of neural networks. GABA is
the main inhibitory neurotransmitter in the brain and
plays a key role in regulating neuronal function [43].
Therefore, we also assessed alterations of astrocytes and
GABA levels in the hippocampus. In TF-induced POCD
mice, excessive reactive astrocytes were detected in the
hippocampus (Fig. 7a) and Sholl analysis of individual
GFAP-positive cells revealed significant differences com-
pared to the control group (Fig. 7b, d; one-way ANOVA,
p < 0.0001, n = 8 per group). Furthermore, levels of Mao
B, a GABA synthesizing enzyme, were significantly
increased in POCD mice (Fig. 7a, c; one-way ANOVA, p
= 0.0003, n = 10 per group). In contrast, Ab injection re-
sulted in the complete restoration of astrocyte
morphology and Mao B expression to control levels (Fig.
7a, c; one-way ANOVA, p = 0.0002, n = 10 per group).
We also assessed GABA levels and found a significant
difference between control and POCD mice (Fig. 7e, f;
one-way ANOVA, p < 0.0001, n = 8 per group).
Increased GABA levels were detected in POCD mice
compared to control mice while Ab injection normalized
GABA levels (Fig. 7e, f; one-way ANOVA, p = 0.0292).
However, mice treated with neutralizing Ab alone with-
out surgery did not show a significant difference in
GABA and Mao B expression as compared with control
group. These results indicated that inhibition of
CX3CR1 signaling by neutralizing Ab injection after TF
surgery suppressed excessive astrocyte activation and ab-
errant GABA expression.
Discussion
In this study, we revealed that transiently elevated
CX3CR1 induces persistent pain and increased expres-
sion of pro-inflammatory cytokines after surgery, which
consequently leads to astrocyte activation and increased
GABA expression, eventually resulting in cognitive dys-
function. Moreover, we revealed the therapeutic effect of
inhibiting CX3CR1 signaling in TF-induced POCD mice.
In summary, inhibition of CX3CR1 signaling by injection
of neutralizing Ab suppressed the increase in pro-
inflammatory cytokines via inhibition of persistent pain
that occurred after TF surgery; it also ameliorated cogni-
tive impairment. Further, inhibition of CX3CR1
Fig. 5 Anti-inflammatory effect of inhibition of CX3CR1 signaling in tibial fracture-induced POCD mice. The levels of the pro-inflammatory
cytokines TNF-α, IL-6, and IL-1β in the prefrontal cortex, the hippocampus, and the amygdala (one-way ANOVA with Tukey’s post hoc, n = 3~10
per group). Control, normal control group; TF2D, 2 days after tibial fracture surgery group; TF+Ab, 2 days after tibial fracture surgery group
injected with neutralizing Ab; Control+Ab, normal control group injected with neutralizing Ab. *p < 0.05; **p < 0.01; ***p < 0.0001 compared to
the control; #p < 0.05; ##p < 0.01; ###p < 0.0001 compared to TF2D
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signaling restored basal CBV, astrocyte activation, and
GABA levels.
The pathogenesis of POCD is still unclear, but one
core pathophysiological mechanism of POCD involves
neuroinflammation caused by postoperative systemic in-
flammation [44, 45]. The ineluctable systemic inflamma-
tion and pain after surgery induce microglia activation,
which leads to induction of inflammatory mediators
such as pro-inflammatory cytokines (TNF-α, Il-6, Il-1β)
and chemokines (CX3CR1), which leads to persistent
pain [8–11]. CX3CR1, as a receptor for CX3CL1, is a
chemokine receptor known to be related to pain, and
CX3CR1/L1 signaling is implicated in the pathogenesis
of inflammatory diseases such as atherosclerosis,
rheumatoid arthritis, and renal fibrosis by supporting
monocyte recruitment and exacerbating tissue damage
[46, 47]. Moreover, CX3CL1/R1 signaling regulates hip-
pocampal neurogenesis, synaptic pruning, and synaptic
plasticity in different pathological conditions [48]. In this
study, we observed microglia activation (Supplementary
Figure S1) and increased pro-inflammatory cytokines,
including IL-6, IL-1β, and TNF-α in several brain re-
gions. Further, 2 days after the surgery, increased
CX3CR1 was detected compared to that in control. In
the von Frey test, mechanical allodynia persisted for 5
days after the surgery. In addition, cognitive dysfunction
was detected until 5 days after the surgery. These results
indicated that increased CX3CR1 contributes to pain de-
velopment, which in turn induces cognitive dysfunction.
Interestingly, we observed a change in astrocyte
morphology, also known as activated astrocytes. Astro-
cytes play a crucial role in maintaining CNS homeostasis
by cross-talk with neurons or microglia [49, 50]. How-
ever, in pathological conditions, the phenotype and func-
tion of astrocytes can change; these altered astrocytes
are known as reactive astrocytes [51]. Indeed, abnormal
astrocytes, such as in gliosis and excessive reactive
astrocytes, cause synaptic imbalances that can induce
cognitive impairment [52]. Recently studies have stated
that astrocyte activation is associated with the develop-
ment of pain by releasing signaling molecules [53, 54].
In addition, activated astrocytes in the brain regions
Fig. 6 Impaired neurovascular coupling response to sensory stimulation in POCD. a Representative image of the intensity changes of the optical
imaging signal during whisker stimulation. b Time course traces of relative changes in cerebral blood volume after stimulation. c Average of the
maximum cerebral blood volume response (one-way ANOVA with Tukey’s post hoc test, n = 4 or 6 per group). Control, normal control group;
TF2D, 2 days after tibial fracture surgery group; TF+Ab, 2 days after tibial fracture surgery group injected with neutralizing Ab. **p < 0.01
compared to the control; ##p < 0.01 compared to TF2D
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related to emotion regulation, such as the primary som-
atosensory cortex, medial prefrontal cortex, and hippo-
campus, are associated with emotional dysfunction
under chronic pain states [55–57]. Thus, based on these
study results, our result is meaningful because an in-
creased level of Mao B, a GABA synthesis associated en-
zyme, was observed in reactive astrocytes. Moreover,
increased GABA expression was observed in the hippo-
campus Indeed, previous studies revealed aberrant astro-
cyte and GABA levels in an Alzheimer’s disease mouse
model, which is characterized by cognitive impairment
[58]. These results indicated that astrocyte activation
was triggered by increased CX3CR1/L1 signaling, which
consequently leads to increased GABA and proinflam-
matory cytokine expression in the hippocampus. Conse-
quently, these changes may have affected cognitive
dysfunction.
Previous studies show that high levels of CX3CR1/L1
signaling are directly proportional to increased levels of
inflammatory factors [59]. Also, expression of CX3CR1
and CX3CL1 is regulated by inflammatory stimuli and is
enhanced following exposure to lipopolysaccharides,
pro-inflammatory cytokines, and during inflammatory
conditions in endothelial and epithelial cells [21]. These
studies may support the reason for the increased
CX3CR1 or CX3CL1 through increased systemic inflam-
mation after surgery. In contrast, deficient CX3CR1
signaling ameliorates the pathological condition in vari-
ous models, such as those for spinal cord injury and
hepatic encephalopathy [32, 60–62]. In neuropathic pain
and mechanical hypersensitivity models, neutralizing
CX3CL1 Ab attenuated peripheral hyperalgesia by
decreasing microglia activation [63]. Similarly, we ob-
served that inhibition of CX3CR1 signaling by CX3CL1
neutralizing Ab injection improved cognitive dysfunction
and prevented the increase in pro-inflammatory cytokine
levels as well as mechanical allodynia. Also, inhibited ac-
tivation of microglia and astrocytes was observed, which
normalized GABA expression. GABA is a major inhibi-
tory neurotransmitter in the CNS and regulates the
Fig. 7 Effect of inhibition of CX3CR1 signaling on GFAP, Mao B expression, and GABA levels. a Representative immunofluorescence images for
DAPI, GFAP, and Mao B. b Sholl analysis for a traced individual GFAP-positive astrocyte, which is superimposed over concentric circles (one-way
ANOVA with Tukey’s post hoc test, n = 8 per group). c Intensity of Mao B images. d Quantification of the total number of intercepts with
ramifications from Sholl analysis (one-way ANOVA with Tukey’s post hoc test, n = 10 per group). a Representative immunofluorescence images
for DAPI and GABA. b Quantification of GABA-positive cells (one-way ANOVA with Tukey’s post hoc test, n = 8 per group). Control, normal control
group; TF_Veh, 2 days after tibial fracture surgery group injected with saline; TF_Ab, 2 days after tibial fracture surgery group injected with
neutralizing Ab; Control+Ab, normal control group injected with neutralizing Ab; scale bar, 20 μm, 100 μm. *p < 0.05; **p < 0.01; ***p < 0.0001
compared to the control; #p < 0.05; ##p < 0.01; ###p < 0.0001 compared to TF2D
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balance of excitation and inhibition required for cogni-
tive ability. Aberrant GABA levels can impair working
memory [28]. GABA has recently also been found to
correlate with a marker of behavioral metrics, which in-
creased the interest in measuring GABA levels to predict
diseases [64, 65]. A previous study showed that glutam-
ate decarboxylase (GAD), a GABA synthesizing enzyme,
was regulated in a spinal cord injury model in CX3CR1-
deficient rats [66]. In addition, another study reported
that in an Alzheimer’s disease animal model, increased
levels of GABA and Mao B in reactive astrocytes caused
memory impairments [29]. Based on these data, we sug-
gest that regulation of CX3CR1/L1 signaling by injection
of neutralizing Ab after surgery affected the level of
GABA expression and mechanical allodynia, which
might consequently improve cognitive impairment.
Neurovascular coupling, i.e., the interactions between
neurons, astrocytes, and cerebral blood vessels [67, 68],
affects normal brain function and the release of neuro-
transmitters, neuromodulators, and vasoactive mediators
[69]. The measurement of hemodynamic responses by
utilizing OIS and functional MRI provide a means to
assess neurovascular coupling. Hemodynamic responses,
including CBV, are correlated with various factors that
regulate neuronal activity and energy production.
GABAergic inhibitory neurons are known to play an im-
portant role in regulating hemodynamic responses. In
the cortex, exogenous GABA has been shown to regulate
CBV [70] but not in the cerebellum. Previous studies
have revealed impaired CBV in dementia and Alzhei-
mer’s disease. In line with these reports, our results re-
vealed that decreased CBV in the POCD model indicate
decreased hemodynamic responses and neurovascular
coupling [40]. Clinical data also showed that the level of
occipital GABA inversely correlates with CBV [71]. Col-
lectively, we suggest that cognitive dysfunction following
TF surgery is closely related to CBV reduction and alter-
ations in neuronal activation, i.e., excitatory/inhibitory
imbalance. Furthermore, our results revealed that CBV
amplitude recovered in the Ab-injected surgery group.
Thus, TF-induced POCD mice displayed decreased
hemodynamic responses to sensory stimulation, which is
likely to be related to brain dysfunctions such as cogni-
tive impairment, whereas the inhibition of CX3CR1/L1
signaling attenuated the reduction in hemodynamic
responses following sensory stimulation. Consequently,
our results suggest that the CX3CR1/L1 signaling
pathway-mediated GABA imbalance and increased in-
flammatory cytokines following TF surgery could be the
main causes of cognitive dysfunction.
There are many potential diseases in which inhibiting
the CX3CL1/R1 signaling pathway may be promising. For
instance, after peripheral nerve injury [72, 73], CX3CR1 is
upregulated in spinal microglia, and a spinal nerve
transection model shows increased CX3CL1 expression in
astrocytes [72]. In addition, intrathecal administration of
CX3CL1 or CX3CR1 neutralizing Ab has protective ef-
fects in attenuating neuropathic pain behaviors in periph-
eral injury models by reducing p38 MAPK
phosphorylation [74, 75]. In a bone cancer model, the de-
velopment of pain occurs concurrently with microgliosis
and an increase in the expression of microglial CX3CR1
and p-p38. Via intrathecal administration of a CX3CR1
neutralizing Ab, the onset of pain is significantly attenu-
ated [76, 77]. Furthermore, pain-mediated neuronal sig-
naling and neuroinflammation were ameliorated by
CX3CL1 neutralizing Ab administration in multiple scler-
osis and hepatic encephalopathy models [60, 78]. Not only
have neutralizing Ab and modified CX3CL1 been used in
proof-of-concept preclinical studies, CX3CR1 antagonists
have also shown anti-inflammatory activities in both mice
and humans [79, 80]. Likewise, several studies have re-
ported positive effects on pathological mechanisms by
inhibiting CX3CR1/L1 signaling via neutralizing Ab, a
mechanism that is related to inhibition of microglia activa-
tion and inflammation response.
Limitations
Several studies have reported the protective effect of
CX3CR1/L1; however, this is the first study to state that
the regulation of CX3CR1/L1 can improve cognitive im-
pairment after surgery via modulation of GABA expres-
sion, which is mediated by the regulation of astrocyte
activation. However, there is a limitation to our study.
As an additional control for the Ab-injected group, we
should have had an IgG-injected group. Instead, we con-
firmed that treatment with neutralizing Ab alone with-
out surgery did not show a significant difference as
compared with control group.
Although further studies are needed to investigate the
detailed molecular mechanism underlying astrocyte acti-
vation and GABA signaling induced by changes in the
CX3CR1/L1 interaction during surgical pain, this study
is the first to show that microglia activation by increased
postoperative systemic inflammation induces a change
in CX3CR1/L1 signaling and causes persistent pain and
astrocyte activation, which consequently alters the level
of neurotransmitters such as GABA, eventually leading
to cognitive impairment. This study further confirmed
the potential therapeutic effects of regulating CX3CR1/
L1 signaling to prevent cognitive impairment in POCD,
via modulation of persistent pain and inflammatory re-
sponse, as well as GABA signaling, by regulating astro-
cyte activation.
Conclusion
Transient increased CX3CR1 after surgery is both neces-
sary and sufficient to induce cognitive dysfunction.
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Neutralizing antibody blockade of CX3CR1/L1 signaling
prevented POCD by reducing pro-inflammatory cytokine
expression as well as regulating GABA levels in the
hippocampus by regulating astrocyte activation. Inhib-
ition of CX3CR1/L1 signaling could be an important tar-
get for therapeutic strategies to prevent the development
of POCD.
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